About The Event
- Beginning Level
- Participants will be able to describe the modified
risk claims that General Snus can now employ.
- Participants will identify implications of modified
risk claims on smokeless tobacco products in regard
to tobacco initiation, use patterns and cessation.
- Participants will be able to discuss the role of the
addictions nurse in educating patients on tobacco product modified risk claims.
It is imperative for addictions nurses to stay up to date on the policy landscape around tobacco products with Modified Risk claims. The aim of this poster is to provide an overview of the recent approval by the United States (U.S.) Food and Drug Administration (FDA) of a Modified Risk Tobacco Product Application (MRTPA) submitted by Swedish Match USA Inc. This is the first time the FDA has authorized marketing tobacco products using the modified risk pathway. The MRTPA includes eight snus products sold under the General name and will allow for the products to marketed with a claim: “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” Although rates of Snus use remain low in the U.S. this policy change is concerning given the use of Snus as a means to help U.S. smokers quit has not been supported by the current research suggesting that the U.S. experience may not be similar to that of the Swedish experience. Further, marketing this product as decreased risk could increase uptake rates in youth and other populations who frequently use smokeless tobacco projects (e.g. rural populations and athletes) as well as has the potential to increase dual product use. Addictions nurses should be prepared to educate patients about all tobacco products and their risk including those with modified risk claims and provide evidenced-based prevention and cessation strategies to patients.
PhD, MPH, FNP-BC Duke University
Dr. Noonan is a nurse scientist and registered Family Nurse Practitioner. She received her BSN at Boston College, her MS in Nursing at Georgetown University, her MPH and PhD at the University of Virginia and completed a Post-Doctoral Fellowship at the University of Michigan. Dr. Noonan’s research is focused on understanding tobacco use behaviors and developing innovative tobacco cessation interventions, including digital interventions, with the goal of reducing risk for chronic diseases (e.g., cancer and cardiovascular disease). Dr. Noonan’s work has a strong focus on rural and medically underserved populations. Her current NCI R01 is examining a text-based tobacco cessation intervention in rural and medically underserved populations. Further Dr. Noonan is the Co-Director of the Duke CTSI Special Populations Core and Associate Program Director for the National Clinician Scholars Program (NCSP) at Duke.
MSN, Duke University and Western Carolina University
Professor Fisher started her career at Western Carolina University in 2014 as a mentor for the NN-CaT program. In 2017, Professor Fisher became an adjunct instructor within the Traditional BSN Program. Prior to coming to WCU, Professor Fisher served as the Infection Prevention Specialist at Haywood Regional Hospital. She has functioned in administrative roles as the Director of Acute Care Services at Harris Regional Hospital, and as Director of Patient Care Services for LifePath Hospice and Palliative Care. Professor Fisher has also held nursing positions in administrative nursing supervision, case management, emergency department, orthopedics, clinical education, AHA instruction, and intensive care. Professor Fisher received a Masters of Science in Nursing Administration from East Tennessee State University in 2017. She is currently working towards her Doctorate in Nursing Practice at Duke University. For Professor Fisher’s research project, she explored the relationship of bedside shift report in improving HCAHPS’ nursing communication scores. Professor Fisher is a member of the American Nurses Association and Association for Professionals in Infection Control and Epidemiology.